index - Thérapie génique pour la DMD & physiopathologie du muscle squelettique Accéder directement au contenu

Dernières publications

Chiffres clés

48 Publications avec texte intégral

Open Access

67 %

Mots clés

Calcium CaV subunits Skeletal muscle Cardiomyopathy Human Umbilical Vein Endothelial Cells Gene Expression Regulation/drug effects Cell homeostasis Muscle Strength Gene expression Animals CTNNB1 NNOS Duchenne muscular dystrophy DMD Hear Inhibitors Long QT Diseases Dystrophin-EGFP Invivo Myotendinous junction Inbred C57BL Humans BMD Becker muscular dystrophy BMD Modificateurs de gènes Becker muscular dystrophy Metabolism Molecular Sequence Data Male Delivery Base Sequence Dystrophie musculaire de Becker DMO Gene modifiers Liver Muscles/physiopathology MiARN Activin Receptors Energy Metabolism/drug effects Ex-vivo Multiresolution modeling Centronuclear myopathy MES Hepatocellular carcinoma Mdx mouse Drp1 Allele‐specific silencing therapy Homeostasis Myogenesis DMD Duchenne muscular dystrophy Becker BMD muscular dystrophy Autophagy Knockout Muscular dystrophy Morphogenesis Immunoglobulin Fc Fragments/pharmacology Dystrophie Musculaire de Becker BMD Cardiomyopathie Dystrophie Musculaire de Duchenne DMD LncARN Multi resolution modeling Animal/physiopathology Muscle Cultured Dystrophy Epigenetics Dystrophine Long noncoding RNA Mice Inbred mdx Muscle Biology Mitochondrial fission Cachexia Molecular docking CaVβs Cell Line LKB1 Cell Biology Cells Duchenne DMD dystrophy Dynamin 2 Clinical trials LncRNA DHPR α1S Génomique Muscular Atrophy Dystrophin Antisense oligonucleotides L-Type Exon skipping Genomic Muscular Dystrophy Becker muscular dystrophy BMD Duchenne muscular dystrophy DMD miRNA nNOS Calcium Channels Multi exon skipping CD38 Muscle development Dystrophin central domain NAD+